VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 118 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $794,008 | -42.2% | 183,798 | -11.8% | 0.00% | – |
Q2 2023 | $1,373,283 | +1007.5% | 208,389 | +1734.7% | 0.00% | – |
Q2 2022 | $124,000 | -3.1% | 11,358 | 0.0% | 0.00% | – |
Q1 2022 | $128,000 | -31.6% | 11,358 | -4.3% | 0.00% | – |
Q4 2021 | $187,000 | -59.4% | 11,869 | -57.8% | 0.00% | – |
Q4 2019 | $461,000 | -69.3% | 28,122 | -73.8% | 0.00% | – |
Q1 2017 | $1,502,000 | -43.3% | 107,313 | -35.3% | 0.00% | -100.0% |
Q4 2016 | $2,647,000 | +199.8% | 165,959 | +112.1% | 0.00% | – |
Q3 2015 | $883,000 | -22.4% | 78,240 | -12.7% | 0.00% | – |
Q2 2015 | $1,138,000 | +36.5% | 89,640 | 0.0% | 0.00% | – |
Q1 2015 | $834,000 | -41.2% | 89,640 | -9.5% | 0.00% | – |
Q4 2014 | $1,418,000 | +25.3% | 99,010 | -9.2% | 0.00% | – |
Q3 2014 | $1,132,000 | -44.6% | 109,100 | -13.7% | 0.00% | -100.0% |
Q2 2014 | $2,045,000 | -0.4% | 126,400 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $2,054,000 | – | 126,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,715,000 | $19,345,000 | 7.65% |
Avoro Capital Advisors LLC | 2,124,593 | $23,965,000 | 6.23% |
Asymmetry Capital Management, L.P. | 118,707 | $1,339,000 | 2.98% |
ARMISTICE CAPITAL, LLC | 760,000 | $8,573,000 | 2.93% |
Consonance Capital Management LP | 1,436,796 | $16,207,000 | 2.28% |
Palo Alto Investors LP | 3,997,108 | $45,087,000 | 2.17% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,784,157 | $53,965,000 | 2.09% |
PURA VIDA INVESTMENTS, LLC | 247,500 | $2,792,000 | 1.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,943,267 | $21,920,000 | 1.06% |
SPHERA FUNDS MANAGEMENT LTD. | 513,390 | $5,791,000 | 0.74% |